virology and translational medicine, I am eager to contribute to this forum’s mission of advancing interdisciplinary scientific dialogue. My work focuses on host-pathogen interactions and therapeutic innovation, exemplified by my recent publication in Microbiol Res (IF=6.7), where I elucidated transcriptomic responses of BHK21 cells to human coronavirus OC43 infection. This study not only advances antiviral research but also highlights my expertise in high-throughput data analysis.

My commitment to addressing research biases is demonstrated in a 20-year meta-analysis (Front Neuroendocrinol, IF=7.4), which exposed systemic gender disparities in alcohol-related studies—a critical issue for ethical scientific practice. Additionally, my translational work on mesenchymal stem cell therapies (Stem Cell Res Ther, IF=7.5) showcases my ability to bridge basic science and clinical applications.

Joining this forum aligns with my goal to engage with global experts in cross-disciplinary collaboration. I aim to share insights on virology, research ethics, and regenerative medicine while learning from peers tackling challenges in infectious diseases and public health. My track record in publishing high-impact studies (3 first-author papers in Q1 journals) ensures rigorous and actionable contributions to discussions.

I look forward to collaborating with members to foster innovative solutions for pressing biomedical challenges.